130 related articles for article (PubMed ID: 20407806)
1. Cancer prevention by bovine lactoferrin: from animal studies to human trial.
Tsuda H; Kozu T; Iinuma G; Ohashi Y; Saito Y; Saito D; Akasu T; Alexander DB; Futakuchi M; Fukamachi K; Xu J; Kakizoe T; Iigo M
Biometals; 2010 Jun; 23(3):399-409. PubMed ID: 20407806
[TBL] [Abstract][Full Text] [Related]
2. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial.
Kozu T; Iinuma G; Ohashi Y; Saito Y; Akasu T; Saito D; Alexander DB; Iigo M; Kakizoe T; Tsuda H
Cancer Prev Res (Phila); 2009 Nov; 2(11):975-83. PubMed ID: 19861543
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
4. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.
Jiang R; Lönnerdal B
Biochem Cell Biol; 2017 Feb; 95(1):99-109. PubMed ID: 28169560
[TBL] [Abstract][Full Text] [Related]
5. Twenty-five years of research on bovine lactoferrin applications.
Tomita M; Wakabayashi H; Shin K; Yamauchi K; Yaeshima T; Iwatsuki K
Biochimie; 2009 Jan; 91(1):52-7. PubMed ID: 18585434
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin: benefits and mechanism of action against infections.
Yamauchi K; Wakabayashi H; Shin K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):291-6. PubMed ID: 16936799
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse.
Ushida Y; Sekine K; Kuhara T; Takasuka N; Iigo M; Tsuda H
Cancer Lett; 1998 Dec; 134(2):141-5. PubMed ID: 10025873
[TBL] [Abstract][Full Text] [Related]
8. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
9. [Chemoprevention of colorectal cancer].
Herszényi L; Juhász M; Prónai L; Tulassay Z
Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
Sangha S; Yao M; Wolfe MM
Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
[TBL] [Abstract][Full Text] [Related]
12. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine.
Iigo M; Alexander DB; Xu J; Futakuchi M; Suzui M; Kozu T; Akasu T; Saito D; Kakizoe T; Yamauchi K; Abe F; Takase M; Sekine K; Tsuda H
Biometals; 2014 Oct; 27(5):1017-29. PubMed ID: 24867408
[TBL] [Abstract][Full Text] [Related]
14. Does butyrate protect from colorectal cancer?
Sengupta S; Muir JG; Gibson PR
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):209-18. PubMed ID: 16460475
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
[TBL] [Abstract][Full Text] [Related]
16. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
Levin B; Lieberman DA; McFarland B; Smith RA; Brooks D; Andrews KS; Dash C; Giardiello FM; Glick S; Levin TR; Pickhardt P; Rex DK; Thorson A; Winawer SJ; ; ;
CA Cancer J Clin; 2008; 58(3):130-60. PubMed ID: 18322143
[TBL] [Abstract][Full Text] [Related]
17. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
Luk GD
Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg AJ; Zakim D
Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
[TBL] [Abstract][Full Text] [Related]
20. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
